The US Food and Drug Administration appears uncertain as to whether COVID-19 vaccines for people under 12 should be granted an emergency use authorization or whether this indication must go through the full licensure process, preview documents released ahead of a 10 June agency advisory committee meeting on COVID vaccines in pediatrics indicate.
The FDA says the Vaccines and Related Biological Products Advisory Committee will be asked to discuss circumstances under which an...





